Developer docs
API playgroundTry for free, no card

Search company profiles

LifeCell International

Full company profile

uuid0002fl4

Namestring
LifeCell International
Legal namestring
LifeCell International Private Limited
Websiteurl
lifecell.in
Company typeenum
Private
Founded yearint
2004
Descriptiontext

LifeCell International Private Limited, founded in 2004 in Chennai, is India's first commercial umbilical cord blood stem cell bank, having licensed technology from CryoCell International (USA). The company has built a diversified healthcare platform anchored by community stem cell banking: under the BabyCord brand, it offers 1-year, 21-year, and 75-year storage plans at INR 20,330 / INR 49,144 / INR 63,551 respectively, tested against 19 parameters, with each subscriber gaining access to a 75,000+ unit shared community inventory that delivers a >97% probability of finding an Indian-origin stem cell match. Underlying technology includes Pentastarch-based cord blood processing (99% red blood cell removal), vapour-phase liquid nitrogen cryopreservation with continuous monitoring and solar-backed energy at twin facilities in Chennai and Jhajjar, and AABB/AATB/CAP/NABL-ISO 15189 accredited operations. The company operates 30+ regional diagnostic laboratories and 500+ collection centres across 2,500+ Indian cities, offering 4,000+ tests from routine health checkups (Ayushman Basic/Total/Vital packages) to oncology, reprogenomics and IVF under the LifeCell Diagnostics brand.

LifeCell monetizes across five revenue streams: subscription stem cell banking (with multi-year contracts and EMI financing through Bajaj Finserv, Pinelabs, Axio, and LiquiLoans), per-test diagnostic services with home sample collection, sale of placental-tissue allograft wound-care products (HuPla FLO, HuPla Matrix, HuPla PHMB) via the Cellution Biologics subsidiary, the AreoVeda natural skincare line for mothers and babies launched in 2024, and B2B hospital lab management contracts covering end-to-end lab setup, operations and accreditation support (including a partnership with the MFine digital health platform). Go-to-market is hybrid: direct-to-consumer online booking and digital marketing target expectant parents and diagnostic consumers, while enterprise field sales target hospitals for lab outsourcing. Subsidiary brands include AreoVeda (wholly-owned natural skincare) and Cellution Biologics (wholly-owned biologics), with corporate restructuring underway via a February 2025 tribunal-approved merger scheme involving CBPL, LifeWell, HS Path and Novocura. The company has cumulatively served 4,50,000+ families, executed 64 Indian and 19 international stem cell retrievals, and remains privately held, having raised capital from Brand Capital (2007), Helion Venture Partners (~$6.4M, 2013), and OrbiMed (~$34.5M, 2021).

Short descriptiontext

LifeCell International is India's first and largest stem cell bank, headquartered in Chennai, offering community umbilical cord blood banking, a 4,000+ test diagnostic lab network, placental-tissue biologics, hospital lab management services, and the AreoVeda natural skincare brand, serving 4.5 lakh+ families across India.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersChennai, India
HQ citystring
Chennai
HQ countrystring
India
HQ regionstring
Asia
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
cord blood banking, stem cell preservation, diagnostic lab services, wound care allografts, community stem cell banking
Industry5 codes
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAJ
Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)
NAICS code3 codes
  • Blood and Organ Banks621991
  • Medical and Diagnostic Laboratories6215
  • Biological Product (except Diagnostic) Manufacturing325414
SIC code4 codes
  • Biological Products, (No Disgnostic Substances)2836
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
  • Pharmaceutical Preparations2834
Product category
Stem Cell Banking
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Stem Cell Banking Services
TypeSubscription Recurring
Description

Annual subscription-based stem cell banking with multiple plan durations (1 year, 21 years, 75 years). Customers pay upfront or through EMI financing. Revenue includes processing fees, storage fees, and optional medical insurance top-ups.

lifecell.in
2Diagnostic/Lab Testing Services
TypeOne Time License
Description

Per-test and package-based diagnostic services covering routine to advanced tests including genetic testing, cancer screening, and reproductive health. Home sample collection available.

lifecell.in
3Allograft/Biologics Products
TypeOne Time License
Description

Sale of biological wound care products derived from human placenta and umbilical cord tissues, including HuPla FLO, HuPla Matrix, and HuPla PHMB.

timesofindia.indiatimes.com
4Skincare Products (AreoVeda)
TypeOne Time License
Description

Sale of skincare products for pregnant women, new mothers, and babies. First natural baby skincare range with ceramides to receive Ecocert certification.

forbesindia.com
5Hospital Lab Management Services
TypeManaged Services
Description

B2B services offering hospitals complete lab setup, management, and optimization. Revenue generated through service contracts with healthcare facilities.

Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales
Pricing details6 tiers
1BabyCord 1 Year Plan - Annual stem cell banking
ModelSubscriptionBilling cadenceAnnual
Notes

₹20,330 per year for 1-year plan with 19 parameters tested

lifecell.in
2BabyCord 21 Years Plan - Medium-term storage
ModelSubscriptionBilling cadenceMulti-year contract
Notes

₹49,144 for 21-year plan (save 55% vs 1-year plan) with 19 parameters tested

lifecell.in
3BabyCord 75 Years Plan - Long-term preservation
ModelSubscriptionBilling cadenceMulti-year contract
Notes

₹63,551 for 75-year plan (save 82% vs 1-year plan) with 19 parameters tested

lifecell.in
4Ayushman Basic Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

₹1,199 (52% off from ₹2,499). 50 tests included. Result within 14 hours.

lifecell.in
5Ayushman Total Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

₹1,499 (42% off from ₹2,599). 79 tests included. Smart report in 14 hours.

lifecell.in
6Ayushman Vital Package
ModelUnit PricingBilling cadencePay-as-you-go
Notes

₹1,999 (54% off from ₹4,299). 81 tests included. Smart report in 14 hours.

lifecell.in
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 of 5 records shown
1AreoVeda
Description

India's first natural baby skincare range with ceramides to receive Ecocert certification, using lab-grown human skin cell models for testing and formulations containing more than 98% natural ingredients.

yourstory.com
+4 more records
Core offering1 text field

LifeCell International operates a community stem cell banking service that preserves umbilical cord blood stem cells for expectant parents and their families, with subscription-based plans ranging from 1-year to 75-year storage. The company also provides pan-India diagnostic laboratory services (4,000+ tests through LifeCell Diagnostics), placental tissue-derived wound care allograft products (HuPla FLO, HuPla Matrix, HuPla PHMB), B2B hospital lab management services, and the AreoVeda natural skincare brand for mothers and babies.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • >97% chance of finding suitable Indian-origin stem cell match
+4 more records
Product overview1 text field

LifeCell International operates a diversified healthcare ecosystem with three core business segments: (1) Community Stem Cell Banking (BabyCord) offering cord blood preservation with 1-year, 21-year, and 75-year storage plans with family coverage and access to 75,000+ cord blood units; (2) LifeCell Diagnostics providing 4000+ laboratory tests including Ayushman health checkup packages (Basic, Total, Vital) and specialized oncology/reprogenomics testing; (3) Health Clinic (Allografts) offering placental tissue-derived wound care products (HuPla FLO, Matrix, PHMB). The company also launched AreoVeda skincare brand in 2024 for mothers and babies, and provides hospital lab management services.

Scale indicator13 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeOEM/ Whitelabel/ Licensing PartnerAnnounced on2004-01-01
Description

Licensed technology from CryoCell International, USA (world's first stem cell bank with 27+ years of experience) to establish India's first stem cell bank in 2004. This partnership enabled LifeCell to bring cord blood banking technology to the Indian market.

Strategic tierSupportingTypeTechnology or Integration
Description

Digital health platform partnership driving access and engagement through corporate health checkups and increased patient walk-ins.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight7 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

India's leading D2C natural baby and maternal skincare brand. Directly competes with AreoVeda on natural, dermatologically-tested skincare for mothers and babies across e-commerce and offline retail channels.

TypeBroad incumbent
Description

One of India's largest diagnostic chains (owned by Agilus Diagnostics) operating 400+ labs. Competes with LifeCell Diagnostics on advanced testing, oncology, and hospital lab management services with deeper brand and corporate hospital contracts.

TypeDirect peer
Description

India's second-largest diagnostic chain operating NABL-accredited labs across India. Directly competes with LifeCell Diagnostics on routine and advanced testing, B2B hospital partnerships, and home sample collection services.

TypeDirect peer
Description

Preventive healthcare-focused diagnostic chain offering affordable health checkup packages directly competing with LifeCell's Ayushman packages. Operates B2B hospital partnerships and home sample collection nationwide.

TypeBroad incumbent
Description

India's largest diagnostic chain with pan-India network of NABL-accredited labs. Competes broadly with LifeCell Diagnostics on routine testing while offering deeper geographic penetration and brand recognition across consumer and hospital channels.

6CordLife India
TypeDirect peer
Description

Direct competitor in Indian cord blood banking market. Both target expectant parents with private and community banking models and similar storage plans. Directly competes for the same Indian middle-class consumer segment with comparable AABB accreditation.

TypeDirect peer
Description

India-based stem cell banking and processing company with private cord blood banking offering and stem cell therapy services. Directly competes with LifeCell on stem cell banking and processing services for Indian customers.

8StemCyte India
TypeDirect peer
Description

US-headquartered cord blood bank with India presence. Competes with LifeCell in private and public banking, particularly leveraging dual inventory from domestic and international cord blood units for higher match probability.

TypeDirect peer
Description

European-origin stem cell bank with India operations. Offers private and family cord blood banking services directly competing with LifeCell on storage plans, accreditation standards, and hospital collection partnerships.

TypeRegional player
Description

UK-headquartered cord blood and tissue bank offering multi-tier storage plans globally. Operates as a regional/overseas alternative that some Indian parents may consider for international storage; benchmark competitor on processing technology and pricing.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance7 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

LifeCell International

Stem Cell Bankinglifecell.in

LifeCell International is India's first and largest stem cell bank, headquartered in Chennai, offering community umbilical cord blood banking, a 4,000+ test diagnostic lab network, placental-tissue biologics, hospital lab management services, and the AreoVeda natural skincare brand, serving 4.5 lakh+ families across India.

What LifeCell International does

LifeCell International Private Limited, founded in 2004 in Chennai, is India's first commercial umbilical cord blood stem cell bank, having licensed technology from CryoCell International (USA). The company has built a diversified healthcare platform anchored by community stem cell banking: under the BabyCord brand, it offers 1-year, 21-year, and 75-year storage plans at INR 20,330 / INR 49,144 / INR 63,551 respectively, tested against 19 parameters, with each subscriber gaining access to a 75,000+ unit shared community inventory that delivers a >97% probability of finding an Indian-origin stem cell match. Underlying technology includes Pentastarch-based cord blood processing (99% red blood cell removal), vapour-phase liquid nitrogen cryopreservation with continuous monitoring and solar-backed energy at twin facilities in Chennai and Jhajjar, and AABB/AATB/CAP/NABL-ISO 15189 accredited operations. The company operates 30+ regional diagnostic laboratories and 500+ collection centres across 2,500+ Indian cities, offering 4,000+ tests from routine health checkups (Ayushman Basic/Total/Vital packages) to oncology, reprogenomics and IVF under the LifeCell Diagnostics brand.

LifeCell monetizes across five revenue streams: subscription stem cell banking (with multi-year contracts and EMI financing through Bajaj Finserv, Pinelabs, Axio, and LiquiLoans), per-test diagnostic services with home sample collection, sale of placental-tissue allograft wound-care products (HuPla FLO, HuPla Matrix, HuPla PHMB) via the Cellution Biologics subsidiary, the AreoVeda natural skincare line for mothers and babies launched in 2024, and B2B hospital lab management contracts covering end-to-end lab setup, operations and accreditation support (including a partnership with the MFine digital health platform). Go-to-market is hybrid: direct-to-consumer online booking and digital marketing target expectant parents and diagnostic consumers, while enterprise field sales target hospitals for lab outsourcing. Subsidiary brands include AreoVeda (wholly-owned natural skincare) and Cellution Biologics (wholly-owned biologics), with corporate restructuring underway via a February 2025 tribunal-approved merger scheme involving CBPL, LifeWell, HS Path and Novocura. The company has cumulatively served 4,50,000+ families, executed 64 Indian and 19 international stem cell retrievals, and remains privately held, having raised capital from Brand Capital (2007), Helion Venture Partners (~$6.4M, 2013), and OrbiMed (~$34.5M, 2021).

LifeCell International firmographics

Firmographics
Name
LifeCell International
Legal name
LifeCell International Private Limited
Website
https://lifecell.in
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
LifeCell International is India's first and largest stem cell bank, headquartered in Chennai, offering community umbilical cord blood banking, a 4,000+ test diagnostic lab network, placental-tissue biologics, hospital lab management services, and the AreoVeda natural skincare brand, serving 4.5 lakh+ families across India.
Ownership category
akta.pro rank

LifeCell International industry classification

Industry
Product category
Stem Cell Banking
NAICS
Blood and Organ Banks (621991), Medical and Diagnostic Laboratories (6215), Biological Product (except Diagnostic) Manufacturing (325414)
SIC
Biological Products, (No Disgnostic Substances) (2836), Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAAAGAE
Cell & Tissue Banking (biobanking, cord blood/tissue)
Healthcare & Life Sciences/Biotechnology & Biologics/Regenerative Medicine & Tissue Engineering
SECONDARYHLAAABAJ
Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring)
Healthcare & Life Sciences/Biotechnology & Biologics/Cell Therapy (autologous/allogeneic)
SECONDARYHLAGADAH
Cell-Based & Potency Assays (Bioassays)
SECONDARYHLAGAMAD
Specialty Pharma & Biologics Distribution (GDP-compliant)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Supply Chain, Logistics & Cold Chain for Life Sciences
SECONDARYHLAGAKAI
Clinical Quality Assurance (GCP QA, TMF/QMS oversight)
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Regulatory Affairs, Quality & Compliance Services (GxP)

Keywords

  • Cord blood banking
  • Stem cell preservation
  • Diagnostic lab services
  • Wound care allografts
  • Community stem cell banking

Where LifeCell International is headquartered

Location

Headquarters

HQ city
Chennai
HQ country
India
HQ region
Asia

Offices3 records

Markets served

LifeCell International business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain, Marketing or Sales

Revenue model

  1. Stem Cell Banking Services: Annual subscription-based stem cell banking with multiple plan durations (1 year, 21 years, 75 years). Customers pay upfront or through EMI financing. Revenue includes processing fees, storage fees, and optional medical insurance top-ups.
  2. Diagnostic/Lab Testing Services: Per-test and package-based diagnostic services covering routine to advanced tests including genetic testing, cancer screening, and reproductive health. Home sample collection available.
  3. Allograft/Biologics Products: Sale of biological wound care products derived from human placenta and umbilical cord tissues, including HuPla FLO, HuPla Matrix, and HuPla PHMB.
  4. Skincare Products (AreoVeda): Sale of skincare products for pregnant women, new mothers, and babies. First natural baby skincare range with ceramides to receive Ecocert certification.
  5. Hospital Lab Management Services: B2B services offering hospitals complete lab setup, management, and optimization. Revenue generated through service contracts with healthcare facilities.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualBabyCord 1 Year Plan - Annual stem cell banking
SubscriptionMulti-year contractBabyCord 21 Years Plan - Medium-term storage
SubscriptionMulti-year contractBabyCord 75 Years Plan - Long-term preservation
Unit PricingPay-as-you-goAyushman Basic Package
Unit PricingPay-as-you-goAyushman Total Package
Unit PricingPay-as-you-goAyushman Vital Package

Go-to-market motion2 records

Distribution channels4 records

Marketing channels5 records

LifeCell International product offering

Product offering

Core offering

LifeCell International operates a community stem cell banking service that preserves umbilical cord blood stem cells for expectant parents and their families, with subscription-based plans ranging from 1-year to 75-year storage. The company also provides pan-India diagnostic laboratory services (4,000+ tests through LifeCell Diagnostics), placental tissue-derived wound care allograft products (HuPla FLO, HuPla Matrix, HuPla PHMB), B2B hospital lab management services, and the AreoVeda natural skincare brand for mothers and babies.

Product overview

LifeCell International operates a diversified healthcare ecosystem with three core business segments: (1) Community Stem Cell Banking (BabyCord) offering cord blood preservation with 1-year, 21-year, and 75-year storage plans with family coverage and access to 75,000+ cord blood units; (2) LifeCell Diagnostics providing 4000+ laboratory tests including Ayushman health checkup packages (Basic, Total, Vital) and specialized oncology/reprogenomics testing; (3) Health Clinic (Allografts) offering placental tissue-derived wound care products (HuPla FLO, Matrix, PHMB). The company also launched AreoVeda skincare brand in 2024 for mothers and babies, and provides hospital lab management services.

Differentiator

Problem solved

Functional benefit

Brands

  • AreoVeda: India's first natural baby skincare range with ceramides to receive Ecocert certification, using lab-grown human skin cell models for testing and formulations containing more than 98% natural ingredients.
  • Cellution Biologics
  • BabyCord
  • StemMatch
  • MFine

Quantifiable outcome

  • >97% chance of finding suitable Indian-origin stem cell match
  • +4 more outcomes

Companies that use LifeCell International

Customer profile

Named customers7 records

Segments5 records

Ideal customer profiles4 records

LifeCell International technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

LifeCell International partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core and supporting.

  • CryoCell International, USAcoreOEM/ Whitelabel/ Licensing Partner · 1 January 2004Licensed technology from CryoCell International, USA (world's first stem cell bank with 27+ years of experience) to establish India's first stem cell bank in 2004. This partnership enabled LifeCell to bring cord blood banking technology to the Indian market.
  • MFinesupportingTechnology or IntegrationDigital health platform partnership driving access and engagement through corporate health checkups and increased patient walk-ins.

Scale indicators13 records

Recent moves6 records

Expansion highlights7 records

LifeCell International competitors and assessment

Company assessment

Direct peers

  • Mamaearth (Honasa Consumer): India's leading D2C natural baby and maternal skincare brand. Directly competes with AreoVeda on natural, dermatologically-tested skincare for mothers and babies across e-commerce and offline retail channels.
  • Metropolis Healthcare: India's second-largest diagnostic chain operating NABL-accredited labs across India. Directly competes with LifeCell Diagnostics on routine and advanced testing, B2B hospital partnerships, and home sample collection services.
  • Thyrocare Technologies: Preventive healthcare-focused diagnostic chain offering affordable health checkup packages directly competing with LifeCell's Ayushman packages. Operates B2B hospital partnerships and home sample collection nationwide.
  • CordLife India: Direct competitor in Indian cord blood banking market. Both target expectant parents with private and community banking models and similar storage plans. Directly competes for the same Indian middle-class consumer segment with comparable AABB accreditation.
  • ReeLabs: India-based stem cell banking and processing company with private cord blood banking offering and stem cell therapy services. Directly competes with LifeCell on stem cell banking and processing services for Indian customers.
  • StemCyte India: US-headquartered cord blood bank with India presence. Competes with LifeCell in private and public banking, particularly leveraging dual inventory from domestic and international cord blood units for higher match probability.
  • CryoSave (now BioSave): European-origin stem cell bank with India operations. Offers private and family cord blood banking services directly competing with LifeCell on storage plans, accreditation standards, and hospital collection partnerships.

Broad incumbents

  • SRL Diagnostics: One of India's largest diagnostic chains (owned by Agilus Diagnostics) operating 400+ labs. Competes with LifeCell Diagnostics on advanced testing, oncology, and hospital lab management services with deeper brand and corporate hospital contracts.
  • Dr. Lal PathLabs: India's largest diagnostic chain with pan-India network of NABL-accredited labs. Competes broadly with LifeCell Diagnostics on routine testing while offering deeper geographic penetration and brand recognition across consumer and hospital channels.

Regional players

  • Cells4Life: UK-headquartered cord blood and tissue bank offering multi-tier storage plans globally. Operates as a regional/overseas alternative that some Indian parents may consider for international storage; benchmark competitor on processing technology and pricing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

LifeCell International social profiles

Digital presence

LifeCell International compliance and trust

Trust signal

Compliance7 records

LifeCell International financial estimates

Financial estimate

Revenue estimate

Valuation estimate

LifeCell International leadership team

Management profile

Number of profiles

Profiles3 records

LifeCell International subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

LifeCell International funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

LifeCell International M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LifeCell International

What does LifeCell International do?

LifeCell International operates a community stem cell banking service that preserves umbilical cord blood stem cells for expectant parents and their families, with subscription-based plans ranging from 1-year to 75-year storage. The company also provides pan-India diagnostic laboratory services (4,000+ tests through LifeCell Diagnostics), placental tissue-derived wound care allograft products (HuPla FLO, HuPla Matrix, HuPla PHMB), B2B hospital lab management services, and the AreoVeda natural skincare brand for mothers and babies.

Is LifeCell International a public or private company?

LifeCell International is a private company. It is classified as venture growth investor backed and is currently operating.

When was LifeCell International founded?

LifeCell International was founded in 2004. It employs 1,001 to 5,000 people.

Where is LifeCell International based?

LifeCell International is headquartered in Chennai, India, in the Asia region.

How does LifeCell International make money?

Five revenue lines are on record. Stem Cell Banking Services are the primary driver. The others are diagnostic/Lab Testing Services, allograft/Biologics Products, skincare Products (AreoVeda) and hospital Lab Management Services.

Who are LifeCell International's main competitors?

Direct peers on record are Mamaearth (Honasa Consumer), Metropolis Healthcare, Thyrocare Technologies, CordLife India, ReeLabs, StemCyte India and CryoSave (now BioSave). Broad incumbents are SRL Diagnostics and Dr. Lal PathLabs. Cells4Life is listed as a regional player.

Does LifeCell International have an API?

No public API is recorded for LifeCell International.

What industry is LifeCell International in?

LifeCell International's product category is Stem Cell Banking. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue), with a secondary code of HLAAABAJ, Cell Therapy Clinical Services & Treatment Centers (apheresis, administration, monitoring). Its NAICS code is 621991 and its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
The Times of IndiaLifeCell International partners with Shraddha Diagnostics to expand advanced diagnostics across GujaratLifeCell International has entered into a strategic partnership with Shraddha Diagnostics to expand advanced diagnostic services across Gujarat. The joint venture, operating under the name Shraddha LifeCell, will leverage Shraddha's regional laboratory network and LifeCell's specialized technical capabilities to offer approximately 4,500 diagnostic tests.BW Healthcare WorldLifeCell, Shraddha Diagnostics Partner To Expand Specialised Testing In GujaratShraddha Diagnostics and LifeCell International have formed a strategic partnership under the Shraddha LifeCell entity to expand specialised diagnostic services across Gujarat. The collaboration combines Shraddha's regional laboratory network with LifeCell's scientific capabilities, offering patients access to approximately 4,500 diagnostic tests.The TribuneLifeCell International Partners with Shraddha Diagnostics to Expand Advanced Diagnostics Across GujaratLifeCell International partnered with Shraddha Diagnostics to expand advanced diagnostic services across Gujarat, combining their respective regional presence and technological infrastructure. The partnership aims to provide the entire state access to a broad range of diagnostics, including genomics, oncology, transplant, and IVF tests.Indian Economic ObserverLifeCell International Partners with Shraddha Diagnostics to Expand Advanced Diagnostics Across GujaratLifeCell International has entered into a strategic partnership with Shraddha Diagnostics to expand advanced diagnostic services across Gujarat, India. The collaboration combines LifeCell's specialized scientific capabilities with Shraddha's regional laboratory network to create the 'Shraddha LifeCell' entity, offering approximately 4,500 diagnostic tests. This move supports LifeCell's broader strategy of integrating routine diagnostics with its genomics and specialized testing portfolio.Digital Health NewsLifeCell International Partners with Shraddha Diagnostics to Expand Advanced Diagnostic Services Across GujaratLifeCell International partnered with Shraddha Diagnostics to expand advanced diagnostic services across Gujarat, focusing on improving diagnostic quality and accessibility. The partnership combines Shraddha Diagnostics' regional presence with LifeCell’s scientific capabilities, offering around 4,500 diagnostic tests and plans to extend services throughout Gujarat.The Times of IndiaNavsari woman wins Rs 20 lakh in stem cell deficiency dispute case | Surat News - The Times of IndiaThe Navsari District Consumer Disputes Redressal Commission directed LifeCell International Pvt Ltd to pay Rs 20 lakh to a 30-year-old woman after finding the company guilty of deficiency in service. The woman had paid Rs 64,710 in January 2024 to preserve her newborn's stem cells for 75 years, with a contractual guarantee of Rs 20 lakh compensation if suitable samples could not be provided. When her husband was diagnosed with leukemia in March 2024, the stored stem cells did not match his requirements, and despite the company's contractual obligation to arrange alternative samples or pay compensation, it failed to do either. The commission also ordered the company to pay Rs 50,000 towards compensation for mental agony and litigation expenses, along with 9% annual interest on the Rs 20 lakh amount.India's NewsLifeCell International Partners with Shraddha Diagnostics to Expand Advanced Diagnostics Across GujaratLifeCell International has partnered with Shraddha Diagnostics to expand advanced diagnostic services across Gujarat. The collaboration leverages Shraddha's regional presence and LifeCell's scientific capabilities, offering around 4,500 tests across the state.Forbes IndiaIndia’s safest, science-backed skincare for moms and babiesLifeCell International, India\'s leading stem cell bank with over 20 years of experience, has launched AreoVeda, a new skincare brand specifically formulated for pregnant women, new mothers, and babies. The brand differentiates itself through cellular-level testing on lab-grown human skin cells and alignment with international safety certifications (EWG verification and Ecocert), addressing a gap in the Indian market for scientifically validated skincare for sensitive life stages. The Indian mother and baby care market is projected to grow significantly, driven by rising consumer awareness and a generational shift toward science-backed, transparent skincare products.GlobeNewswireStem Cell Banking Market Report 2025-2033 | Major Companies Like CBR Systems, China Cord Blood, and Lifecell Play Crucial Roles by Investing in R&D, Fostering Collaborations, and Driving AwarenessThe global stem cell banking market is projected to grow from $8.6 billion in 2024 to $15.5 billion by 2033, a CAGR of 6.48%. Growth is driven by rising awareness of stem cell therapies, delayed parenthood, and cryopreservation advances. North America leads, with major companies investing in R&D and collaborations.